Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety of Low Dose Rivaroxaban Plus Aspirin in Patients With Chronic Coronary Syndrome and High Ischemic Risk

NCT04753372 is registered in ClinicalTrials.gov with Maatschap Cardiologie Zwolle as lead sponsor.

NCT NCT04753372
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04753372 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety of Low Dose Rivaroxaban Plus Aspirin in Patients With Chronic Coronary Syndrome and High Ischemic Risk
Lead sponsor
Maatschap Cardiologie Zwolle
Phase
Observational
Overall status
Completed
Start date
December 21, 2020
Completion date
September 13, 2023
Enrollment
645 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease (cad), peripheral arterial disease (pad)